Ferrer Laboratories   Report issue

For profit Phase 3
Founded: Barcelona Spain (1959)
Status: Left NME R&D (2017)

Organization Overview

First Clinical Trial
2007
NCT01153854
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Dr. Ferrer BioPharma

Active Ingredients

Drugs in Phase 3 Trials (2)

chlorpheniramine (ChlorTrimeton) (2 trials)

Racecadotril (redotil) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2